However, we did not detect any correlation between CD24 levels and tumor location, in contradiction to the findings of Modur et al. [12] and Fugle et al. [20] that noted contradictory trends regarding oncologic outcome and overexpression of CD24 in different subsites of HNSCC. The gene discussed is CD24; the disease is head and neck squamous cell carcinoma.